Alpha-TEA and Trastuzumab for the Treatment of Refractory HER2+ Metastatic Breast Cancer

Clinical trial NCT04120246 · SUSPENDED

Trial details

NCT number: NCT04120246
Sponsor: Veana Therapeutics
Status: SUSPENDED
Phase: Phase 1
Study type: INTERVENTIONAL

Anatomic Stage IV Breast Cancer AJCC v8 HER2 Positive Breast Carcinoma Metastatic Breast Carcinoma Refractory Breast Carcinoma

Start date: 2020-04-08
Primary completion: 2028-02-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.